NYSEAMERICAN:SENS - Senseonics Stock Price, Forecast & News

Senseonics trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "SENS."

Senseonics Holdings Inc (NYSEAMERICAN:SENS) released its quarterly earnings results on Tuesday, November, 12th. The company reported ($0.16) EPS for the quarter, meeting the Zacks' consensus estimate of ($0.16). The firm earned $4.32 million during the quarter, compared to the consensus estimate of $6.18 million. View Senseonics' Earnings History.

Senseonics is scheduled to release their next quarterly earnings announcement on Tuesday, March 10th 2020. View Earnings Estimates for Senseonics.

Senseonics updated its FY 2019 After-Hours earnings guidance on Monday, November, 25th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $$20-22 million, compared to the consensus revenue estimate of $$26.62 million.

6 brokerages have issued 1 year price objectives for Senseonics' shares. Their forecasts range from $1.00 to $2.50. On average, they anticipate Senseonics' stock price to reach $1.90 in the next year. This suggests a possible upside of 100.0% from the stock's current price. View Analyst Price Targets for Senseonics.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Senseonics in the last year. There are currently 4 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Senseonics.

News headlines about SENS stock have trended positive this week, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Senseonics earned a coverage optimism score of 3.0 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for Senseonics.

Some companies that are related to Senseonics include Integral Diagnostics (IDX), Volpara Health Tech (VHT), Akumin (AKU), Exagen (XGN), Profound Medical (PRN), Renalytix Ai (RENX), Palatin Technologies (PTN), Oncosil Medical (OSL), Yourgene Health (YGEN), MaxCyte (MXCT), Lexagene (LXG), BARD1 Life Sciences (BD1), Sernova (SVA), GeneNews (GEN) and Oncimmune (ONC).

Based on aggregate information from My MarketBeat watchlists, some companies that other Senseonics investors own include VirnetX (VHC), CytoDyn (CYDY), Tandem Diabetes Care (TNDM), TransEnterix (TRXC), Sorrento Therapeutics (SRNE), Tetraphase Pharmaceuticals (TTPH), Novavax (NVAX), TherapeuticsMD (TXMD), Advanced Micro Devices (AMD) and Exelixis (EXEL).

Shares of SENS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of SENS stock can currently be purchased for approximately $0.95.

Senseonics has a market capitalization of $193.26 million. Senseonics employs 192 workers across the globe.View Additional Information About Senseonics.

The official website for Senseonics is http://www.senseonics.com/.

Senseonics' mailing address is 20451 Seneca Meadows Pkwy, GERMANTOWN, MD 20876-7005, United States. The company can be reached via phone at +1-301-5157260.